Summary

The eye health products market has seen substantial growth, driven by increased awareness of eye health, especially among the aging population. The market is projected to reach $2.53 billion in 2024 and $4.26 billion by 2031, with a compound annual growth rate (CAGR) of 6.50%.The market's expansion is also propelled by the rising prevalence of eye-related disorders globally. The segment focusing on age-related macular degeneration (AMD) has shown significant growth, indicating a high demand for products targeting this condition. Eye health products currently represent a notable revenue share in the global eye care market.

Sales Analysis and Market Outlook

The eye health products market has experienced steady growth over the past years. Manufacturers, along with government bodies, are actively promoting eye health awareness. This has led to a shift towards using nutritional supplements and preventive medicine to maintain eye health and reduce treatment costs. The market's growth is significantly influenced by the aging population, who are more prone to various eye disorders requiring appropriate treatment and preventive measures.

Eye health products, such as supplements, are increasingly being used to manage age-related eye issues. These products help treat conditions like macular degeneration, retinopathy, cataracts, infections, diabetes mellitus, optic neuritis, trachoma, and dry eye syndrome. Additionally, the rising cases of myopia and vision impairment due to increased screen usage have driven demand for these products. Millennials, in particular, are turning to eye health products to combat digital eye fatigue and myopia.

Factors Driving Market Growth

The market is expected to grow due to several factors, including the development of novel eye health supplements, expanding distribution channels, and effective advertising campaigns. Currently, popular ingredients in eye health products include Lutein, Zeaxanthin, Vitamin A, and Vitamin C. Companies are also introducing innovative ingredients like astaxanthin, blueberries, omega-3 PUFAs, DHA, and genistein to differentiate their products.

Clinical studies are often conducted to verify the effectiveness of these new ingredients. For example, Cyanotech Corporation has carried out numerous clinical trials to study the benefits of astaxanthin on eye health. Companies are also utilizing various distribution channels, such as supermarkets, pharmacies, and online platforms, to reach a broader consumer base. The rise in e-commerce has significantly contributed to increased sales, a trend expected to continue.

The modern lifestyle, characterized by changes in dietary patterns, sedentary behavior, and increased screen usage, has heightened consumers' health concerns. Information about eye care products is widely available through social media, the internet, TV advertisements, and articles, influencing consumer purchasing decisions. Companies are also introducing new eye health-improving products based on consumer interests.

Impact of Regulatory Framework and Product Recalls

The market's growth could be hampered by stringent regulations regarding manufacturing, product safety, and efficacy claims. These regulations vary by region, with some areas imposing strict controls on health benefit claims. Manufacturers must be cautious about the claims they make to avoid regulatory actions.

For instance, Golden Lab LLC received a warning from the FDA after regulatory checks revealed that the company's eye health supplements had issues with purity, strength, and composition. Such regulatory actions can lead to product recalls, which impede market growth. An example includes the recall of eye drops by Altaire Pharmaceuticals due to sterility concerns, highlighting the importance of adherence to manufacturing standards.

Country-wise Market Insights

The U.S. holds a significant share of the global eye health products market, driven by the high prevalence of chronic eye disorders and the availability of commercialized eye health products. The presence of major players and growing consumer awareness further bolster the market in the U.S.

Germany, with its favorable regulatory environment for veterinary products and strong R&D activities, is a key market in Europe. The country's developed insurance sectors and demand for innovative eye health products contribute to its market growth.

China is emerging as a prominent market due to its large patient pool, presence of local market players offering affordable eye health supplements, and growing consumer awareness. The market in China benefits from the penetration of international players and an expanding contract-manufacturing hub.

Category-wise Insights

Lutein and Zeaxanthin are the most widely adopted ingredients in eye health products, primarily due to their effectiveness in treating various eye disorders like AMD, retinopathy, uveitis, and cataracts. The growing public awareness of these supplements' benefits and recommendations from clinicians and ophthalmologists drive this segment's dominance.

Age-related macular degeneration (AMD) is the leading indication generating demand for eye health products. AMD is a common cause of blindness, particularly in high-income countries with aging populations. The increasing prevalence of AMD worldwide significantly impacts the market's growth.

Capsules are the preferred form of eye health products due to their wide availability, affordability, and long shelf life. This segment's growth is driven by consumer preference for capsule formulations, which are widely accepted among patients of all age groups.

Competition Analysis

Major players in the eye health products market are expanding their market share through acquisitions of local and small manufacturing companies. They are also adopting advertising strategies and online campaigns to promote their products. For instance, Bausch + Lomb's LUMIFY® Redness Reliever Eye Drops were approved by Health Canada, and the company introduced PreserVision AREDS 2 Formula mini gel eye vitamins in the U.S.

Key companies in the market include The Nature's Bounty Co., Pfizer Inc., Amway International, Bausch + Lomb, Nutrivein, ZeaVision LLC, Kemin Industries, Inc., EyeScience, Nutrachamps, Bausch Health Companies Inc., and Vitabiotics Ltd. These companies are continuously innovating and expanding their product offerings to meet the growing demand for eye health products.

Key Segments in Eye Health Products Industry Research

• Ingredient: Lutein and Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Astaxanthin, Alpha-Lipoic Acid, and Other Ingredients.

• Indication: Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, and Other Indications.

• Form: Tablet, Capsule, and Others.

• Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Eye Health Products Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Eye Health Products Market Outlook, 2019-2031
3.1. Global Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
3.1.1. Key Highlights
3.1.1.1. Lutein and Zeaxanthin
3.1.1.2. Antioxidants
3.1.1.3. Omega-3 Fatty Acids
3.1.1.4. Coenzyme Q10
3.1.1.5. Flavonoids
3.1.1.6. Astaxanthin
3.1.1.7. Alpha-Lipoic Acid
3.1.1.8. Other Ingredients
3.2. Global Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
3.2.1. Key Highlights
3.2.1.1. Age-related Macular Degeneration (AMD)
3.2.1.2. Cataract
3.2.1.3. Dry Eye Syndrome
3.2.1.4. Other Indications
3.3. Global Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
3.3.1. Key Highlights
3.3.1.1. Tablet
3.3.1.2. Capsule
3.3.1.3. Others
3.4. Global Eye Health Products Market Outlook, by Region, Value (US$ Bn), 2019-2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Eye Health Products Market Outlook, 2019-2031
4.1. North America Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
4.1.1. Key Highlights
4.1.1.1. Lutein and Zeaxanthin
4.1.1.2. Antioxidants
4.1.1.3. Omega-3 Fatty Acids
4.1.1.4. Coenzyme Q10
4.1.1.5. Flavonoids
4.1.1.6. Astaxanthin
4.1.1.7. Alpha-Lipoic Acid
4.1.1.8. Other Ingredients
4.2. North America Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
4.2.1. Key Highlights
4.2.1.1. Age-related Macular Degeneration (AMD)
4.2.1.2. Cataract
4.2.1.3. Dry Eye Syndrome
4.2.1.4. Other Indications
4.3. North America Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
4.3.1. Key Highlights
4.3.1.1. Tablet
4.3.1.2. Capsule
4.3.1.3. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
4.4.1. Key Highlights
4.4.1.1. U.S. Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
4.4.1.2. U.S. Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
4.4.1.3. U.S. Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
4.4.1.4. Canada Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
4.4.1.5. Canada Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
4.4.1.6. Canada Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Eye Health Products Market Outlook, 2019-2031
5.1. Europe Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
5.1.1. Key Highlights
5.1.1.1. Lutein and Zeaxanthin
5.1.1.2. Antioxidants
5.1.1.3. Omega-3 Fatty Acids
5.1.1.4. Coenzyme Q10
5.1.1.5. Flavonoids
5.1.1.6. Astaxanthin
5.1.1.7. Alpha-Lipoic Acid
5.1.1.8. Other Ingredients
5.2. Europe Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
5.2.1. Key Highlights
5.2.1.1. Age-related Macular Degeneration (AMD)
5.2.1.2. Cataract
5.2.1.3. Dry Eye Syndrome
5.2.1.4. Other Indications
5.3. Europe Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
5.3.1. Key Highlights
5.3.1.1. Tablet
5.3.1.2. Capsule
5.3.1.3. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
5.4.1. Key Highlights
5.4.1.1. Germany Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.2. Germany Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.3. Germany Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.4. U.K. Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.5. U.K. Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.6. U.K. Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.7. France Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.8. France Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.9. France Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.10. Italy Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.11. Italy Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.12. Italy Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.13. Turkey Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.14. Turkey Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.15. Turkey Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.16. Russia Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.17. Russia Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.18. Russia Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.19. Rest of Europe Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.20. Rest of Europe Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.21. Rest of Europe Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Eye Health Products Market Outlook, 2019-2031
6.1. Asia Pacific Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
6.1.1. Key Highlights
6.1.1.1. Lutein and Zeaxanthin
6.1.1.2. Antioxidants
6.1.1.3. Omega-3 Fatty Acids
6.1.1.4. Coenzyme Q10
6.1.1.5. Flavonoids
6.1.1.6. Astaxanthin
6.1.1.7. Alpha-Lipoic Acid
6.1.1.8. Other Ingredients
6.2. Asia Pacific Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
6.2.1. Key Highlights
6.2.1.1. Age-related Macular Degeneration (AMD)
6.2.1.2. Cataract
6.2.1.3. Dry Eye Syndrome
6.2.1.4. Other Indications
6.3. Asia Pacific Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
6.3.1. Key Highlights
6.3.1.1. Tablet
6.3.1.2. Capsule
6.3.1.3. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
6.4.1. Key Highlights
6.4.1.1. China Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.2. China Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.3. China Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.4. Japan Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.5. Japan Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.6. Japan Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.7. South Korea Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.8. South Korea Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.9. South Korea Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.10. India Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.11. India Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.12. India Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.13. Southeast Asia Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.14. Southeast Asia Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.15. Southeast Asia Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.16. Rest of Asia Pacific Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.17. Rest of Asia Pacific Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.18. Rest of Asia Pacific Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Eye Health Products Market Outlook, 2019-2031
7.1. Latin America Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
7.1.1. Key Highlights
7.1.1.1. Lutein and Zeaxanthin
7.1.1.2. Antioxidants
7.1.1.3. Omega-3 Fatty Acids
7.1.1.4. Coenzyme Q10
7.1.1.5. Flavonoids
7.1.1.6. Astaxanthin
7.1.1.7. Alpha-Lipoic Acid
7.1.1.8. Other Ingredients
7.2. Latin America Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
7.2.1. Key Highlights
7.2.1.1. Age-related Macular Degeneration (AMD)
7.2.1.2. Cataract
7.2.1.3. Dry Eye Syndrome
7.2.1.4. Other Indications
7.3. Latin America Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
7.3.1. Key Highlights
7.3.1.1. Tablet
7.3.1.2. Capsule
7.3.1.3. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
7.4.1. Key Highlights
7.4.1.1. Brazil Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.2. Brazil Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.3. Brazil Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.1.4. Mexico Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.5. Mexico Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.6. Mexico Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.1.7. Argentina Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.8. Argentina Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.9. Argentina Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.1.10. Rest of Latin America Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.11. Rest of Latin America Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.12. Rest of Latin America Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Eye Health Products Market Outlook, 2019-2031
8.1. Middle East & Africa Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
8.1.1. Key Highlights
8.1.1.1. Lutein and Zeaxanthin
8.1.1.2. Antioxidants
8.1.1.3. Omega-3 Fatty Acids
8.1.1.4. Coenzyme Q10
8.1.1.5. Flavonoids
8.1.1.6. Astaxanthin
8.1.1.7. Alpha-Lipoic Acid
8.1.1.8. Other Ingredients
8.2. Middle East & Africa Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
8.2.1. Key Highlights
8.2.1.1. Age-related Macular Degeneration (AMD)
8.2.1.2. Cataract
8.2.1.3. Dry Eye Syndrome
8.2.1.4. Other Indications
8.3. Middle East & Africa Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
8.3.1. Key Highlights
8.3.1.1. Tablet
8.3.1.2. Capsule
8.3.1.3. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
8.4.1. Key Highlights
8.4.1.1. GCC Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.2. GCC Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.3. GCC Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.4. South Africa Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.5. South Africa Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.6. South Africa Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.7. Egypt Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.8. Egypt Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.9. Egypt Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.10. Nigeria Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.11. Nigeria Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.12. Nigeria Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.13. Rest of Middle East & Africa Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.14. Rest of Middle East & Africa Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.15. Rest of Middle East & Africa Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Indication vs By Form Heat map
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Pfizer Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. The Nature's Bounty Co.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Amway International
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Bausch + Lomb
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Nutrivein
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. ZeaVision LLC
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Kemin Industries, Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. EyeScience
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Nutrachamps
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Bausch Health Companies Inc.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Vitabiotics Ltd.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations